Skip to content
Search AI Powered

Latest Stories

PSNC publishes transition plan from Pharmacy Earlier Payment Scheme to Advance Payments

As the government is winding down the Pharmacy Earlier Payment Scheme (PEPS), all community pharmacy contractors will be able to receive earlier advance payments from November.

To assist contractors in switching to the new mode of payment, the Pharmaceutical Services Negotiating Committee (PSNC) published transition arrangements and timeline for existing PEPS pharmacy contractors.


PSNC director of Pharmacy Funding, Mike Dent, said, the transition arrangements will include a “one-off bridging payment for contractors using PEPS to be paid on November 1, 2021, to be recovered in equal parts over the following 11 months.”

The arrangement will help to ease any cashflow concerns and to provide time for contractors to review their finances, he said.

Dent added: “Separately, PSNC also used the opportunity presented by these discussions (with government) to progress conversations about introducing earlier Advance Payments for all contractors – these were successful in moving the Advance Payments earlier for those contractors who want to do so.”

As per the new payment system, contractors, who make their monthly FP34C submissions through the Manage Your Service (MYS) portal by November 5, will receive payments about 20 days earlier than the current timetable.

More For You

weight-loss websites - your local pharmacist

Many Independents offers a weight loss management programme that doesn’t have a faceless dealer

Pic credit: iStock

Avoid rogue weight-loss websites - your local pharmacist is the safest way to lose those pounds

By Jeremy Meader

More than a quarter of adults in England are considered clinically obese, which puts tremendous strain on healthcare services.

Keep ReadingShow less
Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
Pharmacies warn against buying unlicensed hay fever treatment Kenalog® online

Kenalog® can cause serious mental health problems.

gettyimages

Don’t buy unlicensed hay fever drug Kenalog® online, pharmacies warn

Patients are being urged to avoid buying unlicensed medications such as Kenalog® online to treat hay fever symptoms this spring, as pharmacists report a sharp rise in public interest in the drug.

The National Pharmacy Association (NPA), which represents over 6000 independent community pharmacies, has warned patients that buying medication from unregulated sellers, such as beauty salons and from social media sites, could serious health risks.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less